Canada Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Report Overview

Table of Contents

1578.7

Select License Type

£1,578.70	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,157.40	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,736.10	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,578.70	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Market Research
Country	Canada
Published	2 June 2009
Number of Pages	107
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct

Canada Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Canada diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Canada

Scope

- The report provides diabetes care devices information broken down into detailed categories and segments in Canada.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the diabetes care devices market in Canada.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£1,578.70	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,157.40	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,736.10	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£1,578.70	Add to Wishlist
Change Currency	GBP EURO USD

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets Covered in the Report 10
3.1 Diabetic Care Devices 10
3.2 Glucose Monitoring Devices 10
3.2.1 Blood Glucose Meters 10
3.2.2 Blood Glucose Strips 10
3.3 Insulin Delivery 10
3.3.1 Insulin Pens 10
3.3.2 Insulin Syringes 11
3.3.3 Insulin Pumps 11
3.3.4 Traditional Insulin Pump Accessories 11
4 Healthcare Sector Review 12
4.1 Healthcare Expenditure 12
4.2 Healthcare Infrastructure 16
4.3 Healthcare Policy 20
4.4 Canada Healthcare Trade Statistics 21
5 Regulation System 22
5.1 Medical Equipment Approval Process 22
5.1.1 Classification 22
5.1.2 Conformity Assessment 23
5.1.3 License Fee 25
5.1.4 License Application Processing Duration 25
5.2 Labeling and Packaging 25
5.3 Post-Market Surveillance 26
6 Pricing and Reimbursement 27
7 Distribution Structure 29
7.1 Distribution Structure 29
8 Diabetes Care Devices In Canada 30
8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 30
8.2 Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015 31
8.3 Diabetes Care Devices, Canada, Category Volume (Units), 2000-2015 35
8.4 Diabetes Care Devices, Canada, Company Share (2007-2008) 38
9 Glucose Monitoring In Canada 39
9.1 Glucose Monitoring Overall Revenue (2000-2015) 39
9.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 40
9.2 Glucose Monitoring Overall Volume (2000-2015) 42
9.2.1 Blood Glucose Meters Overall Volume (2000-2015) 43
9.3 Glucose Monitoring Average Price (2000-2015) 45
9.4 Glucose Monitoring Distribution Share (2007-2008) 46
9.5 Glucose Monitoring, Canada, Company Share (2007-2008) 47
10 Insulin Delivery In Canada 48
10.1 Insulin Delivery Overall Revenue (2000-2015) 48
10.1.1 Insulin Pens Overall Revenue (2000-2015) 50
10.2 Insulin Delivery Overall Volume (2000-2015) 52
10.2.1 Insulin Pens Overall Volume (2000-2015) 53
10.3 Insulin Delivery Average Price (2000-2015) 55
10.4 Insulin Delivery Distribution Share (2007-2008) 56
10.5 Insulin Delivery, Canada, Company Share (2007-2008) 57
11 Overview of Key Companies in Canada Diabetes Care Devices Market 58
11.1 F. Hoffmann-La Roche Ltd. 58
11.1.1 Company Overview 58
11.1.2 Value Chain Analysis 59
11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 61
11.2 Bayer HealthCare AG 62
11.2.1 Company Overview 62
11.2.2 Value Chain Analysis 63
11.2.3 Bayer HealthCare AG Pipeline Products 65
11.3 LifeScan, Inc. 66
11.3.1 Company Overview 66
11.3.2 LifeScan, Inc. Pipeline Products 66
11.4 Abbott Laboratories 68
11.4.1 Company Overview 68
11.4.2 Value Chain Analysis 69
11.4.3 Abbott Laboratories Pipeline Products 71
11.5 Novo Nordisk A/S 73
11.5.1 Company Overview 73
11.5.2 Novo Nordisk A/S Pipeline Products 73
11.6 Sanofi-Aventis 75
11.6.1 Company Overview 75
11.7 Medtronic, Inc. 76
11.7.1 Company Overview 76
11.7.2 Value Chain Analysis 77
11.7.3 Medtronic, Inc. Pipeline Products 79
11.8 Terumo Corporation 87
11.8.1 Company Overview 87
11.8.2 Value Chain Analysis 87
11.9 Apex Biotechnology Corp. 90
11.9.1 Company Overview 90
11.10 Becton, Dickinson and Company 91
11.10.1 Company Overview 91
11.10.2 Value Chain Analysis 91
11.11 Eli Lilly and Company 93
11.11.1 Company Overview 93
11.11.2 Value Chain Analysis 93
11.11.3 Eli Lilly and Company Pipeline Products 96
11.12 Animas Corporation 97
11.12.1 Company Overview 97
11.13 Smiths Medical 98
11.13.1 Company Overview 98
11.13.2 Value Chain Analysis 99
11.14 Glucoplus Inc. 101
11.14.1 Company Overview 101
12 Appendix 102
12.1 Global Markets Direct Research Methodology 102
12.2 Coverage 103
12.3 Secondary Research 103
12.4 Primary Research 104
12.5 Models 104
12.6 Forecasts 105
12.7 Expert Panel Validation 105
12.8 Currency Conversion 106
12.9 Contact Us 107
12.10 Disclaimer 107

1.1 List of Tables
Table 1: Healthcare Expenditure, Canada, 2000-2007 15
Table 2: Number of Physicians by Province in Canada, 2001 and 2005 16
Table 3: Number of Physicians by Province in Canada, 2001 and 2007 17
Table 4: Hospital Wards by Specialty in Canada, 2003-2007 18
Table 5: Doctors by Specialty in Canada, 2003-2007 19
Table 6: Canada Healthcare Trade Statistics, 2001-2006 21
Table 7: Medical Equipment Classification in Canada, 2007 22
Table 8: Medical Equipment Licensing Fee in Canada, 2007 25
Table 9: Medical Equipment License Processing Duration in Canada, 2007 25
Table 10: Private Reimbursement Providers, Canada 28
Table 11: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 30
Table 12: Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015 31
Table 13: Diabetes Care Devices, Canada, Cross-Category Analysis, 2000-2015 32
Table 14: Diabetes Care Devices, Canada, Overall Revenue ($ mn), Historic, 2000-2008 33
Table 15: Diabetes Care Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015 34
Table 16: Diabetes Care Devices, Canada, Category Volume (Units), 2000-2015 35
Table 17: Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2000-2008 36
Table 18: Diabetes Care Devices, Canada, Category Volume (Units), Forecast, 2008-2015 37
Table 19: Diabetes Care Devices, Canada, Company Share by Revenue ($ mn), 2007-2008 38
Table 20: Glucose Monitoring, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 39
Table 21: Glucose Monitoring, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 39
Table 22: Blood Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 40
Table 23: Blood Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 41
Table 24: Glucose Monitoring, Canada, Volume (Units) by Segment, Historic, 2000-2008 42
Table 25: Glucose Monitoring, Canada, Volume (Units) by Segment, Forecast, 2008-2015 42
Table 26: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008 43
Table 27: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 44
Table 28: Glucose Monitoring, Canada, Average Price ($), Historic, 2000-2008 45
Table 29: Glucose Monitoring, Canada, Average Price ($), Forecast, 2008-2015 45
Table 30: Glucose Monitoring, Canada, Distribution Share by Revenue ($mn), 2007-2008 46
Table 31: Glucose Monitoring, Canada, Company Share by Revenue ($ mn), 2007-2008 47
Table 32: Insulin Delivery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Table 33: Insulin Delivery, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 49
Table 34: Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 50
Table 35: Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 51
Table 36: Insulin Delivery, Canada, Volume (Units) by Segment, Historic, 2000-2008 52
Table 37: Insulin Delivery, Canada, Volume (Units) by Segment, Forecast, 2008-2015 52
Table 38: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008 53
Table 39: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 54
Table 40: Insulin Delivery, Canada, Average Price ($), Historic, 2000-2008 55
Table 41: Insulin Delivery, Canada, Average Price ($), Forecast, 2008-2015 55
Table 42: Insulin Delivery, Canada, Distribution Share by Revenue ($mn), 2007-2008 56
Table 43: Insulin Delivery, Canada, Company Share by Revenue ($ mn), 2007-2008 57
Table 44: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 61
Table 45: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 61
Table 46: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 61
Table 47: Bayer HealthCare AG Pipeline Products by Equipment Type 65
Table 48: Bayer HealthCare AG Pipeline Products by Development Stage 65
Table 49: Bayer HealthCare AG Pipeline Products by Therapy Area 65
Table 50: Bayer HealthCare AG Pipeline Products by News Summary 65
Table 51: LifeScan, Inc. Pipeline Products by Equipment Type 66
Table 52: LifeScan, Inc. Pipeline Products by Development Stage 66
Table 53: LifeScan, Inc. Pipeline Products by Therapy Area 66
Table 54: LifeScan, Inc. Pipeline Products by Clinical Trials 67
Table 55: LifeScan, Inc. Pipeline Products by News Summary 67
Table 56: Abbott Laboratories Pipeline Products by Equipment Type 71
Table 57: Abbott Laboratories Pipeline Products by Development Stage 71
Table 58: Abbott Laboratories Pipeline Products by Therapy Area 71
Table 59: Abbott Laboratories Pipeline Products by Clinical Trials 72
Table 60: Abbott Laboratories Pipeline Products by News Summary 72
Table 61: Novo Nordisk A/S Pipeline Products by Equipment Type 73
Table 62: Novo Nordisk A/S Pipeline Products By Development Stage 73
Table 63: Novo Nordisk A/S Pipeline Products By Therapy Area 73
Table 64: Novo Nordisk A/S Pipeline Products By Clinical Trials 74
Table 65: Medtronic, Inc. Pipeline Products by Equipment Type 79
Table 66: Medtronic, Inc. Pipeline Products By Development Stage 81
Table 67: Medtronic, Inc. Pipeline Products By Therapy Area 83
Table 68: Medtronic, Inc. Pipeline Products By Clinical Trials 85
Table 69: Medtronic, Inc. Pipeline Products By News Summary 86
Table 70: Eli Lilly and Company Pipeline Products by Equipment Type 96
Table 71: Eli Lilly and Company Pipeline Products by Development Stage 96
Table 72: Eli Lilly and Company Pipeline Products by Therapy Area 96
Table 73: Eli Lilly and Company Pipeline Products by Clinical Trials 96
Table 74: Eli Lilly and Company Pipeline Products by News Summary 96
Table 75: USD to Local Currency, Average Exchange Rate 2008 106

1.2 List of Figures
Figure 1: Healthcare Financing in Canada, 2004 13
Figure 2: Healthcare Expenditure, Canada, 2000 - 2007 14
Figure 3: Diabetes Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 30
Figure 4: Diabetes Care Devices, Canada, Overall Revenue ($ mn), 2000-2015 31
Figure 5: Diabetes Care Devices, Canada, Cross-Category Analysis, 2000-2015 32
Figure 6: Diabetes Care Devices, Canada, Overall Revenue ($ mn), Historic, 2000-2008 33
Figure 7: Diabetes Care Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015 34
Figure 8: Diabetes Care Devices, Canada, Category Volume (Units), 2000-2015 35
Figure 9: Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2000-2008 36
Figure 10: Diabetes Care Devices, Canada, Category Volume (Units), Forecast, 2008-2015 37
Figure 11: Diabetes Care Devices, Canada, Company Share (%), 2008 38
Figure 12: Blood Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 40
Figure 13: Blood Glucose Meters, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 41
Figure 14: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008 43
Figure 15: Blood Glucose Meters, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 44
Figure 16: Glucose Monitoring, Canada, Company Share (%), 2008 47
Figure 17: Insulin Delivery, Canada, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Figure 18: Insulin Delivery, Canada, Revenue ($ mn) by Segment, Forecast, 2008-2015 49
Figure 19: Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 50
Figure 20: Insulin Pens, Canada, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 51
Figure 21: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2008 53
Figure 22: Insulin Pens, Canada, Volume (Units) by Sub-Segment, Forecast, 2008-2015 54
Figure 23: Insulin Delivery, Canada, Company Share (%), 2008 57
Figure 24: F. Hoffmann-La Roche Ltd Value Chain Analysis 59
Figure 25: Bayer HealthCare AG Value Chain Analysis 63
Figure 26: Abbott Laboratories Value Chain Analysis 69
Figure 27: Medtronic, Inc. Value Chain Analysis 77
Figure 28: Terumo Corporation Value Chain Analysis 87
Figure 29: Becton, Dickinson and Company Value Chain Analysis 91
Figure 30: Eli Lilly and Company Value Chain Analysis 93
Figure 31: Smiths Medical Value Chain Analysis 99
Figure 32: Global Markets Direct Methodology 102

Change Currency

GBP

EURO

USD

Last Viewed

Canada Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Argentina Gas Markets Investment Opportunities, Market Analysis and Forecasts to 2020

Colombia Oil Markets Investment Opportunities, Market Analysis and Forecasts to 2020

Colombia Gas Markets Investment Opportunities, Market Analysis and Forecasts to 2020

Spain Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Canada Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel